ACCESS CHINA has been held every quarter since 2020 and serves as a China cross-border corporate access platform. In its 2 years of bringing together international and China Biotech BDs and CEOs, ACCESS CHINA creates invaluable BD opportunities by directly connecting and meeting with the right partners for development, licensing or commercial collaborations. 

We cordially invite you to join our “ACCESS CHINA Biotech Forum Spring Showcase 2022” to be held online from April 18th to 19th, 2022. ACCESS CHINA forum expects to have over 1000 participants from China pharma and Biotech companies. This event is divided into the following sessions:

• US and Australia biotech Company Roadshows (Companies looking for out-licensing in China)
• European and Asia biotech Company Roadshows (Companies looking for out-licensing in China)
• China biotech Company Roadshows (Companies looking for out-licensing in ex-China or global)
• China fundraising Company Roadshows (in Chinese; Companies looking for fundraising in China)

Note: The updated one would be shown at https://biotochina.org/agenda/

We welcome the following global pharma and biotech to showcase:

• Looking for out-/in-licensing opportunities in China
• With clinical-stage pharmaceutical assets
• Focusing on Oncology, CNS, Cardiovascular, Ophthalmology, Orthopedics, Pediatrics, GI, and other therapeutic areas

Who are the attendees?

• 50% are Chinese pharma/biotechs looking for in-licensing opportunities to enrich pipeline
• 25% are Pharma/biotechsoutside China looking for in-licensing opportunities to enrich pipeline in China and other regions
• 15% are VCs and PEs looking for pharma/biotech investment opportunities

previous participants:

We look forward to welcoming you at our Spring showcase in April!

For more information or register as a speaker/attendee, please click: https://biotochina.org/2022/03/15/access-china-biotech-forum-spring-showcase-2022/

Contact Us

Wendi Xiang

wxiang@yafocapital.com